Dominik Nann

6PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyTumour immunologyHaematological tumoursImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 18, 2025
Authors' reply: Re: Yang et al. The road to therapy for myeloid sarcoma: navigating the complexities of subclonal MAPK/ERK mutations and clonal evolution.

Dominik Nann, Falko Fend

|Sep 04, 2025
Myeloid sarcoma shows a high frequency of mutations activating the MAPK/ERK pathway and association with clonal hematopoiesis.

Dominik Nann, Tim-Colin Schade, Mathis Overkamp

|Feb 07, 2024
Clonal haematopoiesis: A common progenitor for cytotoxic peripheral T-cell lymphoma and angioimmunoblastic T-cell lymphoma.

Antonio Vogelsberg, Lennart Harland, Vanessa Borgmann

|Aug 23, 2023
Targeted NGS on sequential bone marrow biopsies aids in the evaluation of cytopenias and monocytosis and documents clonal evolution-a proof of principle study.

Dominik Nann, Achim Rau, Lejla Mahmutovic

|May 24, 2022
A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile.

Julia Salmeron-Villalobos, Caoimhe Egan, Vanessa Borgmann

|May 27, 2020
Forecasting tuberculosis using diabetes-related google trends data.

Leonie Frauenfeld, Dominik Nann, Zita Sulyok

Pageof 1

Frequent Collaborators

5 joint publications

Falko Fend

3 joint publications

Leticia Quintanilla-Martinez

3 joint publications

Irina Bonzheim

1 joint publications

You-Shan Feng